CPHI Share Price | China Pharma Holdings, Inc. Stock Analysis & Recommendation

Q: What does China Pharma Holdings, Inc. do?

Overview: China Pharma Holdings, Inc. is a holding company engaged in the development, manufacture, and marketing of pharmaceutical products for human use in the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company.Financial Snapshot: Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025) Market-cap: USD 5.97 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 0.43 Return on Equity: -63.86% Price to Book: 0.83Contact Details: Address: 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU HAN: 570216 Tel: 86 898 66811730 Website: http://www.chinapharmaholdings.com

Q: Is China Pharma Holdings, Inc. technically bullish or bearish?

As of 2 September 2025, the technical trend for China Pharma Holdings, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while weekly MACD and KST show mild bullishness. Bollinger Bands present a mixed signal with weekly bullishness and monthly mild bearishness. The Dow Theory indicates no trend on a weekly basis and mild bearishness monthly. In terms of multi-period returns, the stock has outperformed the S&P 500 over the past week and month, with returns of 3.97% and 33.67% respectively, but has significantly underperformed over the longer terms, including a -15.48% YTD return compared to the S&P 500's 12.22%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

90.95 k

Shareholding (Mar 2025)

FII

0.77%

Held by 3 FIIs

DII

99.21%

Held by 0 DIIs

Promoter

0.00%

How big is China Pharma Holdings, Inc.?

22-Jun-2025

As of Jun 18, China Pharma Holdings, Inc. has a market capitalization of 5.97 million and reported net sales of 4.29 million with a net profit of -4.57 million over the latest four quarters.

View full answer

What does China Pharma Holdings, Inc. do?

22-Jun-2025

China Pharma Holdings, Inc. is a micro-cap holding company focused on developing, manufacturing, and marketing pharmaceutical products for human use. As of March 2025, it reported net sales of $1 million and a net loss of $1 million, with a market cap of $5.97 million.

View full answer

Who are in the management team of China Pharma Holdings, Inc.?

22-Jun-2025

As of March 2022, the management team of China Pharma Holdings, Inc. includes Zhilin Li (Chairman, President, CEO, Interim CFO), Heung Tsui (Director), and independent directors Gene Bennett, Baowen Dong, and Yingwen Zhang. They oversee the company's operations and strategic direction.

View full answer

Is China Pharma Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, China Pharma Holdings, Inc. shows a mildly bearish trend with mixed signals from moving averages and indicators, having outperformed the S&P 500 in the short term but underperformed year-to-date.

View full answer

Compare China Pharma Holdings, Inc. with Similar Stocks

China Sxt Pharmaceuticals, Inc.NeuBase Therapeutics, Inc.NovaBay Pharmaceuticals, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 6 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.37

Return on Equity

-37.55%

Price to Book

0.73

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-53.15%

6 Months

-54.49%

1 Year

-64.6%

2 Years

-84.0%

3 Years

550.67%

4 Years

-99.7%

5 Years

-99.83%

China Pharma Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-16.68%

EBIT Growth (5y)

-6.99%

EBIT to Interest (avg)

-3.30

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.43

Sales to Capital Employed (avg)

0.51

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

2.37%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.74

EV to EBIT

-1.89

EV to EBITDA

-3.77

EV to Capital Employed

0.82

EV to Sales

1.95

PEG Ratio

Dividend Yield

ROCE (Latest)

-43.26%

ROE (Latest)

-63.86%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 1 Schemes (0.02%)

Foreign Institutions

Held by 3 Foreign Institutions (0.77%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 11.11% vs -18.18% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 64.29% vs -133.33% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.00",
          "val2": "0.90",
          "chgp": "11.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.60",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.50",
          "val2": "-1.40",
          "chgp": "64.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-635.70%",
          "val2": "-1,504.40%",
          "chgp": "86.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -35.71% vs -13.58% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -51.61% vs 22.50% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.50",
          "val2": "7.00",
          "chgp": "-35.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.70",
          "val2": "-3.10",
          "chgp": "-51.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,013.20%",
          "val2": "-392.50%",
          "chgp": "-62.07%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

1.00

0.90

11.11%

Operating Profit (PBDIT) excl Other Income

-0.30

-0.60

50.00%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.50

-1.40

64.29%

Operating Profit Margin (Excl OI)

-635.70%

-1,504.40%

86.87%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 11.11% vs -18.18% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 64.29% vs -133.33% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

4.50

7.00

-35.71%

Operating Profit (PBDIT) excl Other Income

-2.00

0.00

Interest

0.20

0.30

-33.33%

Exceptional Items

0.00

Consolidate Net Profit

-4.70

-3.10

-51.61%

Operating Profit Margin (Excl OI)

-1,013.20%

-392.50%

-62.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -35.71% vs -13.58% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -51.61% vs 22.50% in Dec 2023

All Annual Results

Company CV

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc.

Pharmaceuticals & Biotechnology

China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others.

Company Coordinates

Company Details

2Nd Floor, No. 17, Jinpan Road, Haikou , HAIKOU HAN : 570216

Tel: 86 898 66811730

http://www.chinapharmaholdings.com

Registrar Details

China Pharma Holdings, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is China Pharma Holdings, Inc.?

Watch in Real-Time

What does China Pharma Holdings, Inc. do?

Who are in the management team of China Pharma Holdings, Inc.?

Is China Pharma Holdings, Inc. technically bullish or bearish?

Compare China Pharma Holdings, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About China Pharma Holdings, Inc.

Company Coordinates